NAM.BK Namwiwat Medical
- Market cap
- THB 2.07B
- P/E
- 24.7x
- P/B
- 1.03x
- ROE
- 5.1%
- Dividend yield
- 9.03%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is NAM.BK undervalued?
Graham numberNAM.BK trades 6.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Namwiwat Medical fundamental analysis
No fundamental analysis for Namwiwat Medical yet.
Namwiwat Medical stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Namwiwat Medical
Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company offers steam and low temperature sterilizers, instrument washer disinfectors, ultrasonic cleaning systems, and drying cabinets, as well as waste sterilizers. It also provides NAMTrack, a central sterile supply department software management product, as well as Air Track. In addition, the company offers air and surface disinfection equipment and air puri…
Full company profileNamwiwat Medical financial statements
Namwiwat Medical annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 992M | 1.10B | 1.10B | 1.11B | 1.87B |
| Gross Profit | 401M | 403M | 480M | 468M | 541M |
| Operating Income | 230M | 223M | 250M | 212M | 156M |
| EBITDA | - | 256M | 296M | 282M | 244M |
| Net Income | 175M | 176M | 201M | 181M | 102M |
| EPS | 0.25 | 0.25 | 0.29 | 0.26 | 0.15 |
| Balance Sheet | |||||
| Total Assets | 1.06B | 1.70B | 2.35B | 2.71B | 3.05B |
| Total Liabilities | 621M | 487M | 387M | 614M | 949M |
| Shareholders' Equity | 434M | 1.21B | 1.96B | 2.07B | 2.00B |
| Cash & Short-term Investments | 40.6M | 59.0M | 996M | 921M | 698M |
| Cash Flow | |||||
| Operating Cash Flow | 97.8M | -81.2M | 259M | 22.9M | 37.9M |
| Capital Expenditure | 42.3M | 98.2M | 49.1M | 78.9M | 68.7M |
| Free Cash Flow | 55.5M | -179M | 210M | -56.0M | -30.8M |
| Ratios | |||||
| ROE | 40.2% | 14.5% | 10.2% | 8.7% | 5.1% |
| ROA | 16.6% | 10.4% | 8.5% | 6.7% | 3.3% |
| Net Profit Margin | 17.6% | 16.0% | 18.2% | 16.2% | 5.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Namwiwat Medical dividends
- Dividend yield
- 9.03%
- Forward dividend
- 0.13 THB
- Payout ratio
- 184.1%
- Ex-dividend date
- Mar 13, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | THB 187M | 0.27 | 184.1% |
| 2025 | THB 63.0M | 0.09 | 34.8% |
| 2024 | THB 232M | 0.33 | 115.6% |
| 2023 | THB 243M | 0.35 | 138.0% |
| 2022 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Namwiwat Medical
- Insiders 91.10%
- Institutions 0.57%
- Public & others 8.33%
- Shares outstanding 700M
- Free float 85.8M
Namwiwat Medical company profile
- Company name
- Namwiwat Medical
- Ticker
- NAM.BK
- Exchange
- Thailand Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- June
- Address
- 999/3-5 Moo 9, Samut Prakan, Thailand, 10290
- Phone
- 66 2 461 7287
- Website
- namwiwat.com
About Namwiwat Medical
Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company offers steam and low temperature sterilizers, instrument washer disinfectors, ultrasonic cleaning systems, and drying cabinets, as well as waste sterilizers. It also provides NAMTrack, a central sterile supply department software management product, as well as Air Track. In addition, the company offers air and surface disinfection equipment and air purifiers. Further, it provides medical supplies, disinfection services, medical equipment maintenance services, infectious waste services, and other medical services. The company was founded in 1970 and is based in Samut Prakan, Thailand.
Namwiwat Medical management
7- Mr. Winai PhattiyakulIndependent Chairman of the Board
- Mr. Viroj ChaiturdkietCEO, Acting Chief Officer Sales and Marketing & Director
- Mr. Sukhum PhothisawatChief Accounting & Finance Officer
- Mr. Wisit ChaiturdkietCOO & Director
- Ms. Nantira ChaiturdkietChief Business Support Officer & Director
- Mr. Pongchet KongsakDeputy Chief Executive Officer
- Mr. Wichai ChaiterdkiatDeputy Chief Executive Officer